News & Updates

AONN+ Board Member Andrea (Andi) Dwyer helped lead a three-year collaboration with the CDC and policymakers that resulted in new ICD-10 codes for Lynch Syndrome, BRCA1, BRCA2, and Li-Fraumeni Syndrome, improving coverage and access to genetic testing and diagnostic services for patients.

AONN+ encourages oncology navigators to complete a brief Commission on Cancer survey that will help shape future navigation program development, identify emerging trends, and strengthen support for the oncology navigation community.

AONN+ Midyear 2026 brought the oncology navigation community together for four days of connection, innovation, and practical insights that are shaping the future of patient care.

Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, recently traveled to Philadelphia to represent AONN+ at the Access USA Conference, specifically for Patient Assistance & Access Programs. Here, she took part in the highly popular panel, “The Medicare Patient Experience: Affordability, Access, and the State of Healthcare Today,” which focused on financial burdens that patients with chronic illnesses face and why the work to improve access is far from finished. 

April 3, 2025 – The undersigned cancer organizations, which represent people with cancer; cancer health care professionals; researchers; and caregivers, families and friends of those with cancer, issued the following statement in response to the mass reductions in force at the Department of Health and Human Services (HHS) and the reorganization of the department.

In recent years, patients with chronic conditions, including cancer, have faced harmful "copay diversion programs" such as copay accumulators and maximizers. These programs prevent copay assistance payments from counting toward a patient's annual deductible and out-of-pocket maximums. Once the assistance runs out, patients are left with hundreds or thousands of out-of-pocket costs, even though they should have already reached their yearly maximum.

In light of the recent Executive Order regarding federally backed Diversity, Equity, and Inclusion initiatives, certain materials related to clinical trial diversity have been removed from the FDA website.

AONN+ understands the concern that this creates and assures you that we remain steadfast in our commitment to supporting our members, their patients, and the navigation community through these challenging times.

We encourage all navigators to lean into your AONN+ community and resources, including the Oncology Navigation Standards of Professional Practice as outlined in our recent statement.

Through a generous program, Airbnb and its hosts offer free lodging to patients needing medical stays in areas away from home.